Pancrelipase is a combination of three enzymes (proteins): lipase, protease, and amylase. These enzymes are normally produced by the pancreas and are important in the digestion of fats, proteins, and sugars. Pancrelipase is used to replace these enzymes when the body does not have enough of its own. Certain medical conditions can cause this lack of enzymes, including cystic fibrosis, chronic inflammation of the pancreas, or blockage of the pancreatic ducts.
Pancrelipase is a combination of three enzymes (proteins): lipase, protease, and amylase. These enzymes are normally produced by the pancreas and are important in the digestion of fats, proteins, and sugars. According to the type, it would be made into capsule and tablet, and the capsule is the main type in the world and takes 55.92% of the global production in 2016. According to the different age stage, it can be used by children and adults.
UAS is the biggest manufacturing region in the world for Abbott is the biggest manufacturer in the world with the main factory based in USA. Europe also is a main manufacturing region for the famous company Janssen manufactures pancrelipase in Europe. Japan becomes the main manufacturing region for Abbott has its factory in Japan and some years ago Mylan signed an agreement with Abbott about Creon and other brands to expand Japanese market.
The market concentrate is high and in the world there are mainly four companies such as Abbott
, Janssen, Aptalis and DCI. Abbott is the biggest manufacturer in the world and produced 185.97 K Units, taking 37.26% of the global production.
The global Pancrelipase (CAS 53608-75-6) market is valued at 930 million US$ in 2017 and will reach 1260 million US$ by the end of 2025, growing at a CAGR of 4.3% during 2018-2025.
The major manufacturers covered in this report
New Hope Group
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
Other Regions (India, Southeast Asia, Central & South America and Middle East & Africa)
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of South America
Middle East & Africa
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
The study objectives of this report are:
To analyze and study the global Pancrelipase (CAS 53608-75-6) capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Pancrelipase (CAS 53608-75-6) manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Pancrelipase (CAS 53608-75-6) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Pancrelipase (CAS 53608-75-6) Manufacturers
Pancrelipase (CAS 53608-75-6) Distributors/Traders/Wholesalers
Pancrelipase (CAS 53608-75-6) Subcomponent Manufacturers
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Pancrelipase (CAS 53608-75-6) market, by end-use.
Detailed analysis and profiles of additional market players.